Removal of Endobronchial Malignant Mass by Cryotherapy Improved Performance Status to Receive Chemotherapy

Although malignant endobronchial mass (MEM) has poor prognosis, cryotherapy is reportedly a palliative treatment. Clinical data on postcryotherapy MEM patients in a university-affiliated hospital between 2007 and 2011 were evaluated. Survival curve with or without postcryotherapy chemotherapy and pe...

Full description

Saved in:
Bibliographic Details
Main Authors: Yueh-Fu Fang, Meng-Heng Hsieh, Tsai-Yu Wang, Horng-Chyuan Lin, Chih-Teng Yu, Chun-Liang Chou, Shu-Min Lin, Chih-Hsi Kuo, Fu-Tsai Chung
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2014/369739
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849414188174147584
author Yueh-Fu Fang
Meng-Heng Hsieh
Tsai-Yu Wang
Horng-Chyuan Lin
Chih-Teng Yu
Chun-Liang Chou
Shu-Min Lin
Chih-Hsi Kuo
Fu-Tsai Chung
author_facet Yueh-Fu Fang
Meng-Heng Hsieh
Tsai-Yu Wang
Horng-Chyuan Lin
Chih-Teng Yu
Chun-Liang Chou
Shu-Min Lin
Chih-Hsi Kuo
Fu-Tsai Chung
author_sort Yueh-Fu Fang
collection DOAJ
description Although malignant endobronchial mass (MEM) has poor prognosis, cryotherapy is reportedly a palliative treatment. Clinical data on postcryotherapy MEM patients in a university-affiliated hospital between 2007 and 2011 were evaluated. Survival curve with or without postcryotherapy chemotherapy and performance status (PS) improvement of these subjects were analyzed using the Kaplan-Meier method. There were 59 patients (42 males), with median age of 64 years (range, 51–76, and median performance status of 2 (interquartile range [IQR], 2-3). Postcryotherapy complications included minor bleeding (n=12) and need for multiple procedures (n=10), while outcomes were relief of symptoms (n=51), improved PS (n=45), and ability to receive chemotherapy (n=40). The survival of patients with chemotherapy postcryotherapy was longer than that of patients without such chemotherapy (median, 534 versus 106 days; log-rank test, P=0.007; hazard ratio, 0.25; 95% confidence interval, 0.10–0.69). The survival of patients with PS improvement postcryotherapy was longer than that of patients without PS improvement (median, 406 versus 106 days; log-rank test, P=0.02; hazard ratio, 0.28; 95% confidence interval, 0.10–0.81). Cryotherapy is a feasible treatment for MEM. With better PS after cryotherapy, further chemotherapy becomes possible for patients to improve survival when MEM caused dyspnea and poor PS.
format Article
id doaj-art-67ee3c236657488bbae75833cde2516c
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-67ee3c236657488bbae75833cde2516c2025-08-20T03:33:54ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/369739369739Removal of Endobronchial Malignant Mass by Cryotherapy Improved Performance Status to Receive ChemotherapyYueh-Fu Fang0Meng-Heng Hsieh1Tsai-Yu Wang2Horng-Chyuan Lin3Chih-Teng Yu4Chun-Liang Chou5Shu-Min Lin6Chih-Hsi Kuo7Fu-Tsai Chung8Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taipei, TaiwanDepartment of Internal Medicine, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taipei, TaiwanDepartment of Internal Medicine, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taipei, TaiwanDepartment of Internal Medicine, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taipei, TaiwanDepartment of Internal Medicine, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taipei, TaiwanDepartment of Internal Medicine, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taipei, TaiwanDepartment of Internal Medicine, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taipei, TaiwanDepartment of Internal Medicine, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taipei, TaiwanDepartment of Internal Medicine, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taipei, TaiwanAlthough malignant endobronchial mass (MEM) has poor prognosis, cryotherapy is reportedly a palliative treatment. Clinical data on postcryotherapy MEM patients in a university-affiliated hospital between 2007 and 2011 were evaluated. Survival curve with or without postcryotherapy chemotherapy and performance status (PS) improvement of these subjects were analyzed using the Kaplan-Meier method. There were 59 patients (42 males), with median age of 64 years (range, 51–76, and median performance status of 2 (interquartile range [IQR], 2-3). Postcryotherapy complications included minor bleeding (n=12) and need for multiple procedures (n=10), while outcomes were relief of symptoms (n=51), improved PS (n=45), and ability to receive chemotherapy (n=40). The survival of patients with chemotherapy postcryotherapy was longer than that of patients without such chemotherapy (median, 534 versus 106 days; log-rank test, P=0.007; hazard ratio, 0.25; 95% confidence interval, 0.10–0.69). The survival of patients with PS improvement postcryotherapy was longer than that of patients without PS improvement (median, 406 versus 106 days; log-rank test, P=0.02; hazard ratio, 0.28; 95% confidence interval, 0.10–0.81). Cryotherapy is a feasible treatment for MEM. With better PS after cryotherapy, further chemotherapy becomes possible for patients to improve survival when MEM caused dyspnea and poor PS.http://dx.doi.org/10.1155/2014/369739
spellingShingle Yueh-Fu Fang
Meng-Heng Hsieh
Tsai-Yu Wang
Horng-Chyuan Lin
Chih-Teng Yu
Chun-Liang Chou
Shu-Min Lin
Chih-Hsi Kuo
Fu-Tsai Chung
Removal of Endobronchial Malignant Mass by Cryotherapy Improved Performance Status to Receive Chemotherapy
The Scientific World Journal
title Removal of Endobronchial Malignant Mass by Cryotherapy Improved Performance Status to Receive Chemotherapy
title_full Removal of Endobronchial Malignant Mass by Cryotherapy Improved Performance Status to Receive Chemotherapy
title_fullStr Removal of Endobronchial Malignant Mass by Cryotherapy Improved Performance Status to Receive Chemotherapy
title_full_unstemmed Removal of Endobronchial Malignant Mass by Cryotherapy Improved Performance Status to Receive Chemotherapy
title_short Removal of Endobronchial Malignant Mass by Cryotherapy Improved Performance Status to Receive Chemotherapy
title_sort removal of endobronchial malignant mass by cryotherapy improved performance status to receive chemotherapy
url http://dx.doi.org/10.1155/2014/369739
work_keys_str_mv AT yuehfufang removalofendobronchialmalignantmassbycryotherapyimprovedperformancestatustoreceivechemotherapy
AT menghenghsieh removalofendobronchialmalignantmassbycryotherapyimprovedperformancestatustoreceivechemotherapy
AT tsaiyuwang removalofendobronchialmalignantmassbycryotherapyimprovedperformancestatustoreceivechemotherapy
AT horngchyuanlin removalofendobronchialmalignantmassbycryotherapyimprovedperformancestatustoreceivechemotherapy
AT chihtengyu removalofendobronchialmalignantmassbycryotherapyimprovedperformancestatustoreceivechemotherapy
AT chunliangchou removalofendobronchialmalignantmassbycryotherapyimprovedperformancestatustoreceivechemotherapy
AT shuminlin removalofendobronchialmalignantmassbycryotherapyimprovedperformancestatustoreceivechemotherapy
AT chihhsikuo removalofendobronchialmalignantmassbycryotherapyimprovedperformancestatustoreceivechemotherapy
AT futsaichung removalofendobronchialmalignantmassbycryotherapyimprovedperformancestatustoreceivechemotherapy